Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Devonian Health Group Inc (V: GSD)

 
GSD Technical Analysis
5
As on 23rd Jan 2026 GSD STOCK Price closed @ 11.50 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.15 & Strong Buy for SHORT-TERM with Stoploss of 0.19 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

GSDSTOCK Price

Open 11.50 Change Price %
High 11.50 1 Day 11.31 5952.63
Low 11.50 1 Week 11.31 5952.63
Close 11.50 1 Month 11.32 6288.89
Volume 4300 1 Year 11.32 6288.89
52 Week High 11.50 | 52 Week Low 0.11
 
V Canada Most Active Stocks
SML 1503.80 5.80%
NU 16.76 39.32%
GXU 0.04 0.00%
GSVR 1.04 6.12%
SHL 0.47 -21.67%
INEO 0.02 0.00%
GRSL 0.65 1.56%
AGX 1.35 2.27%
SCD 0.30 %
BEX 0.10 -16.67%
 
V Canada Top Gainers Stocks
KUB 7.50 37400.00%
CEN 19.16 27271.43%
CEN 19.16 27271.43%
CEN 19.16 27271.43%
CEN 19.16 27271.43%
CEN 19.16 27271.43%
PRE 1.55 7650.00%
PRE 1.55 7650.00%
GSD 11.50 5952.63%
HELX 32.31 4096.10%
 
V Canada Top Losers Stocks
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
VEC 43.92 -99.71%
TZR 0.05 -75.00%
ORC-A 20.00 -67.21%
MCM-A 0.27 -65.38%
SGMA 4.18 -63.65%
SGMA 4.18 -63.65%
ATI 0.03 -62.50%
 
 
GSD
Daily Charts		 GSD
Intraday Charts		 Whats New @
Bazaartrend		 GSD
Free Analysis
 
GSD Important Levels Intraday
RESISTANCE11.50
RESISTANCE11.50
RESISTANCE11.50
RESISTANCE11.50
RESISTANCE11.50
RESISTANCE11.50
RESISTANCE11.50
RESISTANCE11.50
 
GSD Forecast January 2026
Share
4th UP Forecast11.73
3rd UP Forecast11.66
2nd UP Forecast11.61
1st UP Forecast11.57
1st DOWN Forecast11.43
2nd DOWN Forecast11.39
3rd DOWN Forecast11.34
4th DOWN Forecast11.27
 
GSD Weekly Forecast
4th UP Forecast11.67
3rd UP Forecast11.62
2nd UP Forecast11.58
1st UP Forecast11.55
1st DOWN Forecast11.45
2nd DOWN Forecast11.42
3rd DOWN Forecast11.38
4th DOWN Forecast11.33
 
GSD Forecast2026
4th UP Forecast33.51
3rd UP Forecast26.45
2nd UP Forecast22.09
1st UP Forecast17.72
1st DOWN Forecast5.28
2nd DOWN Forecast0.91
3rd DOWN Forecast-3.45
4th DOWN Forecast-10.51
 
 
GSD Other Details
Segment EQ
Market Capital 40343144.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
GSD Address
GSD
 
GSD Latest News
 
Your Comments and Response on Devonian Health Group Inc
 
GSD Business Profile
Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, a Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric or duodenal ulcers; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, it acquires drug and health product licenses, as well as distributes pharmaceutical products. Devonian Health Group Inc. has a strategic alliance with CannTx Life Sciences Inc. for the development of cannabinoid-based pharmaceutical drugs. The company was incorporated in 2015 and is headquartered in Québec, Canada. Address: 360, rue des Entrepreneurs, Québec, QC, Canada, G5V 4T1
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service